2022-01-22
1684
分享到：
阿爾茨海默氏癥(Alzheimer’s)研究的抗體在幫助科學家找到治療阿爾茨海默氏癥和其他癡呆癥的方面發揮了重要作用。根據阿爾茨海默氏癥協會(Alzheimer’s Association)的數據，全球有4700萬人和530萬美國人受到這種疾病的影響，預計到2050年，這一數字將增加兩倍。隨著嬰兒潮一代的老齡化，預計將有2800萬人患上這種疾病，成本將上升到美國所有醫療保險支出的近四分之一。
自1906年阿洛伊修斯·阿爾茨海默(Aloysius Alzheimer)博士首次描述這種疾病以來，科學家們在了解這種疾病如何影響大腦方面取得了顯著進展。十多年后，在理解和治療方面的突破為阿爾茨海默氏癥患者帶來了希望。
這些ImmunoStar抗體已在阿爾茨海默氏癥研究中得到證實?，F在已經有數百篇引用這些抗體的出版物。ImmunoStar的抗體穩定、高滴度，且批次間保持一致，以確保成功染色并具有出色的價值。
ImmunoStar 抗體已被證明可用于阿爾茨海默氏癥（Alzheimer’s）的研究
Neuropeptide Y (NPY) is a member of a regulatory peptide family and has a marked sequence homology with pancreatic polypeptide (PP) and peptide YY (PYY), which are other members of the family. NPY is widely expressed in the nervous system and has been shown to be differentially expressed in inhibitory interneurons in the hippocampus in degenerative disease, as a powerful vasoconstrictor in the periphery, and increased expression of NPY in the hypothalamus correlates with food intake.
|
|
The ImmunoStar monoclonal Tyrosine Hydroxylase antiserum was quality control tested using standard immunohistochemical methods. The antiserum demonstrates strongly positive labeling of rat catecholamine neuron systems using indirect immunofluorescent and biotin/avidin-HRP techniques. Recommended primary dilution is 1/4000 – 1/8000 with the biotin/avidin-HRP technique. This antibody has been used successfully for IHC, ICC, FC, and IP.
|
|
The ImmunoStar serotonin antiserum was quality control tested using standard immunohistochemical methods. The antiserum demonstrates strongly positive labeling of rat hypothalamus, raphe nuclei and spinal cord using indirect immunofluorescent and biotin/avidin-HRP techniques.
|
|
血管活性腸肽抗體 VIP (Vasoactive Intestinal Peptide) Antibody #20077 | |
The antibody has a proven strong Biotin-Streptavidin/HRP staining at a 1/4000-1/6000 dilution in rat amygdala, cortex, and suprachiasmatic nucleus.
|
|
| The antiserum demonstrates strongly positive labeling of rat raphe nuclei, hypothalamus, cortex and spinal cord using indirect immunofluorescent and biotin/avidin-HRP techniques. |
|
促腎上腺皮質激素釋放因子抗體 CRF (Corticotropin Releasing Factor) Antibody #20084 | |
| The ImmunoStar antiserum was quality control tested using standard immunohistochemical methods. The antiserum demonstrates strongly positive labeling of rat median eminence using indirect immunofluorescent and biotin/avidin-HRP techniques. |
|
| The antibody has a proven strong biotin-streptavidin/HRP staining at 1/1,000-1/1,200 dilution in rat globus pallidus and amygdala. |
|
阿爾茨海默病和相關疾病的診斷和治療的最新消息、發現和發展。 | |
400-888-0207
